Deborah Murtagh’s Clinical Education Guide

Binder, Chelation & Elimination Guide

We live in continual contact with environmental compounds. Heavy metals, plastic particles and plastic-associated chemicals, PFAS, pesticides, mould compounds, combustion products and microbial metabolites can enter through food, water, air, household materials and the wider environment. We cannot reduce every exposure to zero, which is why lowering avoidable exposure and supporting the body’s ordinary clearance systems should be an ongoing part of health maintenance.

That begins with the gut. The intestinal lining is both an absorptive surface and an immune interface. A diverse microbiome, intact mucus layer, well-regulated intestinal permeability and reliable bowel clearance help determine what remains inside the digestive tract, what crosses into circulation, how the immune system is educated and how microbial and bile-derived metabolites are handled.

Dysbiosis, impaired barrier integrity—often described as “leaky gut”—and slow elimination can increase immune activation and the opportunity for unwanted material to be absorbed or reabsorbed. The gut also communicates bidirectionally with the brain through immune signalling, microbial metabolites, the vagus nerve, endocrine pathways and neurotransmitter-related chemistry. Supporting the gut is therefore not only about digestion: it is part of caring for immune resilience, inflammatory balance, mood, cognition and the gut–brain axis.

“Detoxification” is often spoken about as though every unwanted compound can be removed with the same product. That is not how the biology works. Different compounds have different structures, transport routes and exit pathways.

The right question is not simply, “Which binder should I take?” It is:

What are we trying to capture, where is it currently located, how might it be mobilised, and is there a reliable pathway for it to leave?

Staying on top of cumulative toxin load matters, but the strategy should be intelligent. Food, hydration, microbial restoration, barrier integrity, digestive function, bile flow and regular bowel clearance provide daily support. More concentrated binders and mobilisation agents can then be selected according to the person, the exposure and the exit pathway rather than combined indiscriminately.

BIND

Capture selected compounds inside the digestive tract.

MOVE

Maintain appropriate intestinal movement and stool formation.

MOBILISE

Move stored or circulating compounds towards an exit pathway.

ELIMINATE

Remove material through stool, bile or urine.

A gastrointestinal binder usually acts inside the bowel. A natural chelator or mobilisation agent may interact with compounds that have already been absorbed. Clearance support assists the liver, bile, kidneys, antioxidant systems and bowel. These mechanisms overlap, but they are not interchangeable.

Find the guidance relevant to you

Begin with your bowel phenotype, then explore the relevant binder, chelation or exposure section. Your personalised prescription remains the primary guide for what you should actually use.

Slow Transit Gut Reactive / Fast Transit Gut Low Digestive Capacity Upper Digestive Irritation Resilient Gut Microbiome Rebuild Intestinal binders Natural chelation support Detoxification nutrients Detoxification foods Guidance by target PFAS / PFOA / PFOS Microplastics Quality and safe use

Phenotype guidance

Slow Transit Gut

Primary objective: establish reliable bowel clearance before using strong binders or mobilisation strategies.

When stool remains in the colon for too long, material released into bile or captured by a binder still has no efficient route out. Slow transit also increases the opportunity for bile constituents and other compounds to be reabsorbed. The sequence therefore matters: hydrate, soften and move the stool, then add targeted binding only when needed.

Begin with: adequate fluid and electrolytes, appropriately titrated apple pectin or psyllium, food-based fibre matched to tolerance, regular movement and prescribed bowel support. When magnesium is specifically selected for constipation, the form matters: citrate is commonly used for an osmotic stool-softening effect; oxide or hydroxide may be more explicitly laxative, while glycinate is generally better positioned for magnesium repletion than constipation relief.

Delay or introduce cautiously: daily charcoal, high-dose clay, strongly swelling sodium bentonite, bile-acid sequestrants and natural mobilisation agents. These may worsen retention if bowel emptying is not already dependable.

Phenotype guidance

Reactive / Fast Transit Gut

Primary objective: calm irritation, replace fluid and electrolytes, and improve stool formation without overstimulating the bowel.

Strong bowel-stimulating products and large initial doses of fermentable fibre may increase urgency, cramping, gas or loose stool. Begin with a small amount of gentle stool-forming support and increase only as tolerance becomes clear.

Potentially useful: carefully titrated soluble fibre, pectin, mucosal support, selected yeast-based support and diosmectite when clinically appropriate.

Usually avoid initially: laxative magnesium, stimulant motility products and large fermentable-fibre loads.

Phenotype guidance

Low Digestive Capacity

Primary objective: preserve absorption while supporting digestion and gentle clearance.

When stomach acid, pancreatic output or digestive secretions are compromised, a broad binder taken near meals may capture nutrients, digestive support or medicines before the body can use them.

Potentially useful: gentle food-derived fibre, hydration, modified citrus pectin or low-dose chlorella where tolerated, with binders placed well away from meals, enzymes, minerals and medicines.

Phenotype guidance

Upper Digestive Irritation

Primary objective: avoid aggravating nausea, gastritis or reflux while maintaining an exit pathway.

Gritty powders, concentrated oils, garlic and irritating sulphur products may be poorly tolerated when the upper digestive tract is inflamed. Alginate may be helpful in selected reflux patterns because it forms a physical raft or gel, although this is different from systemic detoxification.

Potentially useful: alginate where appropriate, gentle pectin or other soluble fibre, and low-dose MCP or chlorella if tolerated.

Phenotype guidance

Resilient Gut

Primary objective: maintain low cumulative exposure and strong everyday elimination while matching concentrated tools to a defined purpose.

A resilient bowel still benefits from daily attention to environmental load. Diverse food fibre, hydration, bile flow, movement, microbial diversity and regular stool clearance provide the foundation. Food-based detoxification support can be used consistently, while charcoal, chlorella, pectin or another concentrated binder may be rotated or used intermittently according to exposure, tolerance and clinical purpose.

Phenotype guidance

Microbiome Rebuild

Primary objective: support beneficial organisms and the intestinal barrier without allowing broad adsorbents to disrupt the rebuilding phase.

Frequent charcoal or clay may interfere with nutrients and prescribed products. Pectin, psyllium and other tolerated fibres may be more compatible with longer-term ecosystem repair. Selected yeast products can offer cell-wall adsorption alongside microbiome support, but effects remain product- and toxin-specific.

Mechanism one

Intestinal binders and trapping agents

These agents act predominantly in the digestive tract. Their value depends on what they bind, how strongly they bind it, whether the interaction remains stable through digestion, product purity and whether the bowel is moving reliably.

Apple pectin

AccessibleMOVE + ELIMINATE

Pectin forms a soluble gel that supports stool water, bowel regularity and carriage of bile-associated material. It is a practical food-level foundation, although ordinary apple pectin should not be presented as biologically equivalent to modified citrus pectin.

Psyllium husk

AccessibleStool regulation

Psyllium absorbs water and forms a gel. It can soften hard stool, add form to loose stool and increase faecal clearance of bile constituents. It must be taken with adequate fluid and introduced gradually when bloating or fermentation is prominent.

Activated charcoal

Broad adsorbentIntermittent use

Activated charcoal has a highly porous surface that adsorbs many organic compounds within the gut. It is useful for selected acute ingestions under appropriate guidance and may have a defined intermittent protocol role. It does not bind every poison, is not an effective general metal chelator and may capture medicines, supplements and beneficial compounds.

Important: charcoal commonly causes black stool and may worsen constipation. Keep it well separated from medicines and prescribed nutrients.

Montmorillonite, bentonite and other clays

Mycotoxin-specificPurity critical

Clay is not a single generic substance. Refined calcium montmorillonite has human evidence for reducing selected aflatoxin biomarkers. Calcium bentonite and sodium bentonite differ in swelling behaviour; sodium-dominant products may be more constipating. Diosmectite is better established for diarrhoeal and reactive patterns, while kaolin is primarily stool-firming. Illite has insufficient human evidence for broad automated toxin claims.

Purified clinoptilolite zeolite

Ion exchangeProduct-specific

Clinoptilolite has a lattice structure capable of exchanging ions and interacting with selected charged compounds, including ammonium. Use only purified, independently tested products intended for oral use. Raw mineral powders and vague “liquid zeolite” claims should not be treated as equivalent.

Chlorella

Gentle binderNutritional support

Chlorella combines cell-wall binding potential with chlorophyll, carotenoids, amino acids and minerals. Preclinical research supports interruption of absorption or recirculation of selected contaminants, including dioxins, but it is not proven to remove every metal or mycotoxin. Choose a broken-cell-wall product tested for unwanted metals and microbial contamination.

Chlorophyllin

Aflatoxin interception

Chlorophyllin can form molecular complexes with selected ingested compounds. Its strongest human evidence relates to aflatoxin interception rather than general heavy-metal chelation or universal detoxification.

Yeast cell walls and Saccharomyces boulardii

Mycotoxin adsorptionMicrobiome support

Beta-glucans and mannans in yeast cell walls can adsorb some aflatoxins, ochratoxin and zearalenone under experimental conditions. Binding varies by strain, product and toxin, and some interactions are reversible. S. boulardii may offer a useful dual role in selected patients, but it requires caution in critically ill or severely immunocompromised people.

Mechanism two

Natural chelation, mobilisation and clearance support

These compounds should not be placed in the same category as bowel-lumen binders. Some may complex selected metals, alter distribution, support glutathione or influence urinary and faecal excretion. Mobilisation should only be considered when hydration, mineral status, kidney function and bowel clearance are adequately supported.

Modified citrus pectin (MCP)

MCP has a modified molecular structure and is being investigated for interaction with selected metals and other biological targets. A small uncontrolled human pilot reported increased urinary arsenic and cadmium excretion; the lead result was suggestive but not conventionally significant. This is promising preliminary evidence, not a substitute for medical chelation in confirmed poisoning.

Coriander / cilantro leaf

Coriander contains plant compounds that may interact with selected metals and support antioxidant defences. Evidence for lead, arsenic and cadmium remains predominantly animal-based. Fresh leaf is best positioned as accessible supportive nutrition, not as a proven stand-alone human chelator. Coriander essential oil has different chemistry and should not inherit the chelation claims of the whole leaf.

Garlic and allicin

Garlic’s sulphur compounds may interact with metals while supporting antioxidant and glutathione systems. One occupational human study reported reduced blood lead after four weeks, but replication is needed. Garlic may aggravate reflux and may interact with antiplatelet or anticoagulant medicines.

NAC, glutathione and alpha-lipoic acid

N-acetylcysteine supplies cysteine for glutathione synthesis; glutathione participates in conjugation, redox control and cellular export; alpha-lipoic acid contains sulphur groups and recycles antioxidant systems. These mechanisms are biologically important, but supplementation is not equivalent to clinically proven chelation. Alpha-lipoic acid is a mobilisation tool requiring particular care when clearance is poor.

Selenium and zinc

These minerals may reduce the biological harm of selected metal exposures through competition, enzyme support and altered complex formation. They do not function as simple universal chelators. Selenium has a narrow safety range, and excessive zinc can produce copper deficiency; use should reflect diet, status and the specific exposure.

Cellular clearance support

Detoxification nutrients and compounds

These compounds do not all bind toxins directly. Their value lies in supporting redox balance, conjugation, transport, bile handling and the conversion of some reactive compounds into forms that are easier to eliminate. More is not always better: detoxification pathways require sequencing, cofactors and functioning bowel and kidney clearance.

Glutathione

Glutathione is a central intracellular antioxidant and a substrate for glutathione-S-transferase reactions. It can conjugate selected electrophilic compounds, after which transport systems move conjugates toward bile, urine or the intestinal lumen. Oral, liposomal and clinician-directed intravenous forms are not biologically identical, and supplementation does not guarantee removal of every toxicant.

N-acetylcysteine (NAC)

NAC supplies cysteine, which is often the rate-limiting amino acid for glutathione synthesis. It also has thiol chemistry and independent antioxidant and mucolytic actions. NAC is best understood as glutathione and redox support rather than a universal stand-alone chelator. It can cause nausea and requires review when medicines or specific medical conditions are present.

Glycine and GlyNAC

Glutathione is made from cysteine, glycine and glutamate. In people with high oxidative demand or compromised glutathione synthesis, providing glycine alongside NAC may support glutathione production more effectively than focusing on cysteine alone. Human research is promising, but benefit depends on baseline need.

Alpha-lipoic acid

Alpha-lipoic acid participates in mitochondrial metabolism, regenerates antioxidant systems and contains sulphur groups capable of interacting with selected metals. Because it may mobilise compounds rather than simply bind them in the bowel, it belongs later in a well-sequenced protocol—not automatically at the beginning when elimination is poor.

Selenium, zinc and mineral sufficiency

Selenium supports glutathione peroxidases and may alter the biological effects of mercury and other metals. Zinc supports metallothionein, barrier repair and antioxidant enzymes. Both can be helpful when status warrants them, but excess selenium is toxic and excess zinc can create copper deficiency. Repletion should be purposeful rather than indiscriminate.

B vitamins and methylation support

Folate, vitamin B12, riboflavin, vitamin B6, choline and betaine contribute to one-carbon metabolism, transsulfuration and methylation. These pathways influence the processing of arsenic, hormones, neurotransmitters and many endogenous compounds. The correct form and amount depend on nutrient status, genetics, diet and tolerance; “methylation support” is not a one-formula solution.

Vitamin C and the antioxidant network

Vitamin C helps recycle antioxidants and may reduce oxidative injury associated with some exposures. It is supportive rather than a broad chelator. Larger amounts can cause diarrhoea and may be inappropriate for people with particular kidney or oxalate concerns.

Food-first foundation

Foods that support detoxification and elimination

Food works differently from a concentrated binder. Its daily value is cumulative: it supplies fibre for stool and bile carriage, amino acids for conjugation, polyphenols and pigments for redox signalling, minerals for enzyme systems, and compounds that influence Nrf2 and other cellular defence pathways.

Coriander / cilantro

Fresh coriander is an accessible food with antioxidant phytochemicals and preclinical evidence of interaction with selected metals. Use it regularly in salads, dressings, pestos, soups or juices if tolerated. It is supportive food, not a substitute for testing or medical chelation.

Cruciferous vegetables and broccoli sprouts

Broccoli, broccoli sprouts, cabbage, kale, cauliflower, Brussels sprouts, rocket and watercress provide glucosinolates that can be converted into isothiocyanates such as sulforaphane. These compounds activate Nrf2-related cellular defence and phase-II enzyme systems. Chopping and allowing crucifers to rest before cooking, eating some raw, or adding a source of myrosinase such as mustard may improve conversion.

Garlic, onions, leeks and other alliums

Alliums provide sulphur-containing compounds that support glutathione-related pathways and antioxidant defences. Garlic also has preliminary human evidence in occupational lead exposure. Adjust the amount when reflux, gastritis or fermentative symptoms are active.

Beetroot

Beetroot supplies betalain pigments, betaine, polyphenols and nitrate. Its strongest rationale is antioxidant, vascular, methyl-donor and liver-supportive rather than direct binding of toxins. Whole beetroot also contributes fibre; juice provides different benefits but removes much of the stool-supporting fibre.

Apples, citrus pith and pectin-rich foods

Apples and the white pith of citrus fruit provide natural pectin that forms a gel, supports stool and helps carry bile-associated material through the bowel. These are highly accessible daily foods, although they are not equivalent to therapeutic modified citrus pectin.

Flax, chia, oats and psyllium

Soluble and mucilaginous fibres support stool formation, microbial metabolites and faecal clearance of bile. They must be matched to bowel speed and tolerance. Large initial quantities can aggravate gas, pain or urgency in a reactive or highly fermentative gut.

Leafy greens, herbs and chlorophyll-rich foods

Parsley, spinach, rocket, watercress and other greens provide folate, magnesium, carotenoids, polyphenols and chlorophyll-related compounds. Their role is broad nutritional and antioxidant support; chlorophyll-rich foods should not automatically inherit the targeted aflatoxin evidence for purified chlorophyllin.

Protein and amino-acid sufficiency

The liver’s conjugation systems require amino acids. Eggs, fish, meat, poultry, legumes and other appropriate protein sources provide glycine, cysteine, methionine, taurine and additional substrates used in glutathione production, sulfation, methylation and bile formation. Detoxification can be impaired by under-eating protein even when many “detox foods” are consumed.

Bitter and bile-supportive foods

Rocket, radicchio, chicory, dandelion greens, artichoke, lemon and appropriate dietary fats may support digestive signalling and bile handling. Bile movement matters because many compounds are transported from the liver into bile before reaching the intestine. Gallstones, obstruction or significant biliary pain require individual assessment rather than aggressive stimulation.

A practical daily plate: include an appropriate protein source, one or more cruciferous or bitter vegetables, colourful polyphenol-rich plants, a tolerated source of soluble fibre, fresh herbs such as coriander or parsley, adequate minerals and enough fluid for the chosen fibre load.

Selection logic

Match the strategy to the target

Target	More relevant strategies	Essential qualification
Lead	Exposure removal; medical chelation when indicated; supportive MCP, garlic, coriander, selected exact-strain probiotics, mineral repletion	Blood lead elevation requires source identification and appropriate clinical assessment.
Mercury	Medical chelation when indicated; gut interception with selected chlorella; glutathione-pathway and selenium-status support	Selenium may change toxicity or distribution without necessarily increasing excretion.
Cadmium	Exposure removal; kidney assessment; preliminary MCP support; antioxidant and mineral sufficiency	Kidney status is particularly important; mobilisation is not automatically appropriate.
Arsenic	Remove contaminated water, food or supplement sources; toxicology when significant; preliminary MCP, coriander and sulphur-pathway support	The chemical form and exposure source materially change the risk.
Aflatoxin	Exposure removal; refined calcium montmorillonite; chlorophyllin; selected yeast-wall products	Evidence is product- and toxin-specific.
Ochratoxin A	Exposure remediation; selected charcoal, yeast-wall, clay or bile-recirculation strategies	Direct human treatment evidence remains limited.
Dioxins / PCBs	Reduce exposure; soluble fibre; bile-recirculation strategies; chlorella as emerging support	Much chlorella evidence remains preclinical.
Ammonium	Purified clinoptilolite in selected gastrointestinal contexts; microbiome and bowel-function support	Requires an identified, purified product.

Persistent chemicals

PFAS, PFOA and PFOS

Many PFAS compounds circulate between liver, bile and intestine and may be reabsorbed rather than immediately excreted. This enterohepatic recycling creates a rational target: capture bile in the gut and carry it out through stool.

Human trials now provide emerging evidence for prescription bile-acid sequestrants and specialised anion-exchange resins. Cholestyramine and colesevelam have produced meaningful increases in faecal PFAS elimination or reductions in serum PFOS in small clinical studies. These are clinician-directed strategies because they can cause constipation and interfere with medicines, essential fatty acids and fat-soluble vitamins.

Soluble fibre and regular stool clearance are accessible foundations, although ordinary psyllium or pectin should not be promised to produce the same quantified reductions as prescription sequestrants. An Australian randomised trial also found that plasma and whole-blood donation reduced PFAS levels, with plasma donation producing the larger effect. Donation must remain appropriate to iron, haemoglobin, protein and immunoglobulin status.

Emerging field

Microplastics and plastic-associated chemicals

Microplastics are not one uniform target. Larger particles may remain within the digestive tract, nanoplastics may cross biological barriers, and plastic-associated chemicals such as phthalates and bisphenols follow their own metabolic pathways.

No supplement has yet been established as a universal human microplastic binder. The most defensible strategy is to reduce continued exposure, maintain a strong intestinal barrier and microbiome, use sufficient tolerated fibre, and ensure regular elimination so particles remaining in the gut do not have unnecessarily prolonged contact time.

Emerging animal and laboratory research is examining dietary fibre, selected probiotic strains and microbial cell surfaces. These findings are biologically interesting, but they do not yet justify claiming that ordinary probiotics, charcoal, clay, zeolite or chlorella remove accumulated systemic microplastics from humans.

Practical safeguards

Product quality, timing and safe use

Charcoal: choose plain activated coconut-shell or hardwood charcoal with minimal additives.
Clay: it must be explicitly intended for oral use, identify the mineral type and provide independent contaminant testing.
Zeolite: use purified clinoptilolite supported by a current certificate of analysis.
Chlorella: look for an identified species, broken cell wall and testing for metals and microbial contamination.
Pectin: apple pectin supports stool and bile clearance; use true modified citrus pectin only when MCP is intended.
Psyllium: use plain husk without sweeteners, colours or undisclosed laxative mixtures.
Humic, fulvic and shilajit products: independent batch testing is non-negotiable because poorly controlled products may introduce the very metals they claim to remove.

Medicine separation: a binder may capture a medicine before the body absorbs it. Follow the separation window in your approved plan or obtain advice from your pharmacist or practitioner. Do not guess when the medicine has a narrow therapeutic range.

Bowel-first rule: do not begin a strong constipating binder when you are not passing stool reliably. Captured material still needs to leave the body.

Clinically significant poisoning requires conventional testing and toxicology oversight. Medical chelators such as DMSA, DMPS and EDTA form excretable complexes with particular metals, but they can also remove essential minerals and affect kidney or liver function. Unapproved over-the-counter “chelation” products are not equivalent.

How evidence is interpreted

Clinical observation and published evidence answer different questions

This guide separates human clinical evidence, mechanistic adsorption research, animal evidence, practitioner experience and repeated clinical observation. A repeated change in symptoms, bowel function or microscopy may provide valuable pattern evidence. It does not, on its own, identify the exact compound removed or prove a particular molecular pathway.

This distinction allows useful clinical observations to be retained without presenting an emerging hypothesis as settled fact.

Selected research and safety resources

The governing principle

Reduce the exposure. Establish the exit pathway. Select the mechanism for the actual target. Then replenish what the process may remove.

Your personalised Microbiome Makeover prescription determines which products, if any, belong in your programme. This guide explains the reasoning behind those choices; it is not an instruction to take every option listed.